Display Settings:

Format

Send to:

Choose Destination
    J Low Genit Tract Dis. 2002 Apr;6(2):111-5.

    HAART use in women with HIV and influence on cervical intraepithelial neoplasia: a clinical opinion.

    Source

    Department of Family Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. nkhanna@som.umaryland.edu

    Abstract

    OBJECTIVES:

    Study the role of highly active antiretroviral therapy (HAART) in cervical disease in women with human immunodeficiency virus (HIV) and human papillomavirus (HPV) infections.

    MATERIALS AND METHODS:

    A systematic review of current literature and the results summarized in the following headings: HIV and cytological evidence of disease, HIV and HPV, and HAART and HIV in women with HPV-associated cervical disease.

    RESULTS:

    Limited data is available to study the influence of HAART on HPV-related cervical disease in women with HIV. There is evidence that the use of HAART may lead to immune restoration and thereby prevent severe recurrent HPV disease, thus influencing associated cervical disease.

    CONCLUSIONS:

    Little data is available on HAART and its role in HPV-associated cervical disease in women with HIV. Immune restoration may decrease the severity and recurrence of HPV infection and potentially impact cervical disease. Population-based studies are needed to further evaluate the role of HAART in HPV associated cervical disease.

    PMID:
    17051009
    [PubMed]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk